Understanding Pharma Market Access in the US
With Dr Nick Proctor & Louisa Oliver Byrne
Course Details
The United States is the largest national pharmaceutical market, making up over 40% of total pharmaceutical spending worldwide. Understanding the managed care ecosystems and stakeholders in the US is thus critical knowledge for all managers involved in the global launch of any pharmaceutical.
The US pharmaceutical market is just as complex and diverse as European health systems, with unique payer drivers and pricing and access decision-making differing significantly across market segments. As a set of highly dynamic systems, it is also important to understand the impact of events like the Inflation Reduction Act and the Pharmacy Benefit Manager Transparency Act on commercialisation in this major market.
So, to ensure you are ready to navigate your company/brands towards successful commercial launch in the US, a first step is to grasp the fundamental structure and dynamics of US market access. Secondly, you need to foresee the potential routes to successful market access and how to deal with the most common market access challenges.
This course will give you all of that in just one day! You will have the unique opportunity to ask your specific questions to two outstanding market access experts, and also learn a lot from your international peers in the course.
This is one of the best Market Access trainings I have taken. The course materials were excellent, concise, and very well-structured. I appreciated Nick and Louisa as highly qualified trainers. I also valued the organisation of the course, including the ease of registration and the early delivery of printed and digital materials to review in advance. The pace of the course and the balance with questions and answers were perfect! I gained a lot from the course.
Boehringer Ingelheim
Oramon Nimkannon, Capability Lead Pricing & Contracting - Germany - April 2025
The structure and key players of US Managed Care systems, and how they compare with other global systems.
The scope of medical benefit and how to navigate the pricing and access control mechanisms in this system.
The role and significance of Pharmacy Benefit Managers (PBMs) and how to navigate the pricing and access control mechanisms in the pharmacy benefit system.
The tools and context needed to understand and discuss the potential future impact of the Inflation Reduction Act, increased PBM transparency, and other recent policy decisions.
Strategies for navigating towards successful market access and how to deal with the most common challenges along the way.
A great introduction to exploring the complexity of achieving value for patients in the US.
UCB
Sophie Housiaux, Equitable Access & Policy Lead - Belgium - April 2025
| Welcome & Introductions (~30 min) |
| Understanding US Managed Care Systems (~1 h) |
|
| Navigating the Medical Benefits System (~2 h) |
|
| Lunch Break |
| Navigating the Pharmacy Benefit System (~1 h 45 min) |
|
| Future Outlook (~1 h 30 min) |
|
| Market Access Dynamics in the US (~30 min) |
|
| Final Q&A (~15 min) |
Nick Proctor is a Partner at Access Infinity with over 25 years of experience in pricing, reimbursement, and access projects for many of the world’s top pharma brands. He has worked extensively with payers and providers across all segments of the US managed care system. Nick also supported the US and global launch planning of multiple products during his four years living in the US.
Louisa Oliver Byrne leads Access Infinity’s US Managed Care Centre of Excellence. With over seven years of experience as a global pricing and market access consultant, Louisa has spearheaded numerous US-focused engagements to support evidence generation, payer value stories, and pricing strategies.
Nick has been a CELforPharma faculty member since 2015, and Louisa since 2024. Both are passionate trainers and experts in leading interactive, engaging sessions, ensuring participants gain practical and actionable insights.
Great presentations on the key players in US Market Access, clearly explaining unique payer drivers and the pricing and access decision-making processes in the US. I also enjoyed the insightful discussions around future outlooks and the potential impact of new legislation.
Boehringer Ingelheim
Sine Ilday, Senior Manager Global HCA & Market Access - Germany - April 2025
All in-country market access executives moving to a global role should take this course.
In addition, executives in functions that contribute to market access optimisation in the US will also greatly benefit:
Medical Affairs
Marketing
Clinical Development
Health Outcomes
If you are a consultant, please contact Annelies Swaan, who will check with the faculty whether you can attend.
Would you like to receive a list of anonymised participant profiles from previous sessions?
Email Annelies Swaan
UPCOMING DATES & FORMATS - FEES
22 October 2025
Live online (CET timing)
Early bird € 1 470
(until 19/09/2025)
(Full fee € 1 670)
TIMING & LOCATION
Live Online (CET): Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).
Live Online (EST): Zoom sessions between 8 AM and 4 PM EST (Eastern Standard Time).
Face-to-Face: Held at the Crowne Plaza Brussels Airport (Da Vincilaan 4, 1831 Brussels), between 9 AM and 5 PM CET. Preferential hotel rates available for participants.
All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .
GROUP DISCOUNTS
Team discounts can be offered to 2 or more delegates from the same company.
Email Annelies Swaan, Director Business Operations, for more details.
HOW TO REGISTER
Click the green “Register” button on your preferred course session.
The registration wizard will guide you through the process.Alternatively, download the offline registration form and send the completed form to Annelies Swaan.
PAYMENT OPTIONS
Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).
Bank Transfer: Details provided with your invoice.
For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.
INCLUDED IN THE REGISTRATION FEE
Access to a highly interactive, small-group online course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
VAT INFORMATION
Prices exclude VAT. VAT application depends on course format and your location:
Face-to-Face in Belgium: 21% Belgian VAT applies
Live online courses & self-study programme: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.
TRANSFER & CANCELLATION POLICY
Flexible Transfer
If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.
Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.
Registration Cancellation
Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
The average Recommendation Score from participants of the last session was
9,4/10!
Testimonials from past participants:
This is one of the best Market Access trainings I have taken. The course materials were excellent, concise, and very well-structured. I appreciated Nick and Louisa as highly qualified trainers. I also valued the organisation of the course, including the ease of registration and the early delivery of printed and digital materials to review in advance. The pace of the course and the balance with questions and answers were perfect! I gained a lot from the course.
Boehringer Ingelheim
Oramon Nimkannon, Capability Lead Pricing & Contracting - Germany - April 2025
A great introduction to exploring the complexity of achieving value for patients in the US.
UCB
Sophie Housiaux, Equitable Access & Policy Lead - Belgium - April 2025
Great presentations on the key players in US Market Access, clearly explaining unique payer drivers and the pricing and access decision-making processes in the US. I also enjoyed the insightful discussions around future outlooks and the potential impact of new legislation.
Boehringer Ingelheim
Sine Ilday, Senior Manager Global HCA & Market Access - Germany - April 2025
I can highly recommend this course! Nick and Louisa gave a very clear presentation of the US Market Access systems.
GSK
Florian Toussaint, Market Access and Public Affairs Manager - France - September 2024
Special thanks to Louisa and Nick for their ability to explain complex subjects in a comprehensive manner. I also really appreciate the quality of the provided materials.
Medincell
Bérengère Duhamel, Business Insight and Market Access Leader - France - September 2024
I highly appreciate the structured and business-focused approach in explaining complex healthcare issues with a clear and simple-to-understand story.
Olpha
Elena Bushberg, Executive Director - Latvia - September 2024
People attending this course are typically also interested in the below courses.
Need help to find the right course? Email Inge Cornelis (Director, Client & Product Projects) or call +32 473 65 15 77
Course Details
Dates & Locations
Upcoming Session
22 October 2025, Live online (CET timing)
Early bird € 1 470
(until 19/09/2025)
(Full fee € 1 670)
Prices are excl. VAT
The United States is the largest national pharmaceutical market, making up over 40% of total pharmaceutical spending worldwide. Understanding the managed care ecosystems and stakeholders in the US is thus critical knowledge for all managers involved in the global launch of any pharmaceutical.
The US pharmaceutical market is just as complex and diverse as European health systems, with unique payer drivers and pricing and access decision-making differing significantly across market segments. As a set of highly dynamic systems, it is also important to understand the impact of events like the Inflation Reduction Act and the Pharmacy Benefit Manager Transparency Act on commercialisation in this major market.
So, to ensure you are ready to navigate your company/brands towards successful commercial launch in the US, a first step is to grasp the fundamental structure and dynamics of US market access. Secondly, you need to foresee the potential routes to successful market access and how to deal with the most common market access challenges.
This course will give you all of that in just one day! You will have the unique opportunity to ask your specific questions to two outstanding market access experts, and also learn a lot from your international peers in the course.
This is one of the best Market Access trainings I have taken. The course materials were excellent, concise, and very well-structured. I appreciated Nick and Louisa as highly qualified trainers. I also valued the organisation of the course, including the ease of registration and the early delivery of printed and digital materials to review in advance. The pace of the course and the balance with questions and answers were perfect! I gained a lot from the course.
Boehringer Ingelheim
Oramon Nimkannon, Capability Lead Pricing & Contracting - Germany - April 2025
The structure and key players of US Managed Care systems, and how they compare with other global systems.
The scope of medical benefit and how to navigate the pricing and access control mechanisms in this system.
The role and significance of Pharmacy Benefit Managers (PBMs) and how to navigate the pricing and access control mechanisms in the pharmacy benefit system.
The tools and context needed to understand and discuss the potential future impact of the Inflation Reduction Act, increased PBM transparency, and other recent policy decisions.
Strategies for navigating towards successful market access and how to deal with the most common challenges along the way.
A great introduction to exploring the complexity of achieving value for patients in the US.
UCB
Sophie Housiaux, Equitable Access & Policy Lead - Belgium - April 2025
| Welcome & Introductions (~30 min) |
| Understanding US Managed Care Systems (~1 h) |
|
| Navigating the Medical Benefits System (~2 h) |
|
| Lunch Break |
| Navigating the Pharmacy Benefit System (~1 h 45 min) |
|
| Future Outlook (~1 h 30 min) |
|
| Market Access Dynamics in the US (~30 min) |
|
| Final Q&A (~15 min) |
Nick Proctor is a Partner at Access Infinity with over 25 years of experience in pricing, reimbursement, and access projects for many of the world’s top pharma brands. He has worked extensively with payers and providers across all segments of the US managed care system. Nick also supported the US and global launch planning of multiple products during his four years living in the US.
Louisa Oliver Byrne leads Access Infinity’s US Managed Care Centre of Excellence. With over seven years of experience as a global pricing and market access consultant, Louisa has spearheaded numerous US-focused engagements to support evidence generation, payer value stories, and pricing strategies.
Nick has been a CELforPharma faculty member since 2015, and Louisa since 2024. Both are passionate trainers and experts in leading interactive, engaging sessions, ensuring participants gain practical and actionable insights.
Great presentations on the key players in US Market Access, clearly explaining unique payer drivers and the pricing and access decision-making processes in the US. I also enjoyed the insightful discussions around future outlooks and the potential impact of new legislation.
Boehringer Ingelheim
Sine Ilday, Senior Manager Global HCA & Market Access - Germany - April 2025
All in-country market access executives moving to a global role should take this course.
In addition, executives in functions that contribute to market access optimisation in the US will also greatly benefit:
Medical Affairs
Marketing
Clinical Development
Health Outcomes
If you are a consultant, please contact Annelies Swaan, who will check with the faculty whether you can attend.
Would you like to receive a list of anonymised participant profiles from previous sessions?
Email Annelies Swaan
UPCOMING DATES & FORMATS - FEES
22 October 2025
Live online (CET timing)
Early bird € 1 470
(until 19/09/2025)
(Full fee € 1 670)
TIMING & LOCATION
Live Online (CET): Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).
Live Online (EST): Zoom sessions between 8 AM and 4 PM EST (Eastern Standard Time).
Face-to-Face: Held at the Crowne Plaza Brussels Airport (Da Vincilaan 4, 1831 Brussels), between 9 AM and 5 PM CET. Preferential hotel rates available for participants.
All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .
GROUP DISCOUNTS
Team discounts can be offered to 2 or more delegates from the same company.
Email Annelies Swaan, Director Business Operations, for more details.
HOW TO REGISTER
Click the green “Register” button on your preferred course session.
The registration wizard will guide you through the process.Alternatively, download the offline registration form and send the completed form to Annelies Swaan.
PAYMENT OPTIONS
Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).
Bank Transfer: Details provided with your invoice.
For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.
INCLUDED IN THE REGISTRATION FEE
Access to a highly interactive, small-group online course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
VAT INFORMATION
Prices exclude VAT. VAT application depends on course format and your location:
Face-to-Face in Belgium: 21% Belgian VAT applies
Live online courses & self-study programme: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.
TRANSFER & CANCELLATION POLICY
Flexible Transfer
If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.
Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.
Registration Cancellation
Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
The average Recommendation Score from participants of the last session was
9,4/10!
Testimonials from past participants:
This is one of the best Market Access trainings I have taken. The course materials were excellent, concise, and very well-structured. I appreciated Nick and Louisa as highly qualified trainers. I also valued the organisation of the course, including the ease of registration and the early delivery of printed and digital materials to review in advance. The pace of the course and the balance with questions and answers were perfect! I gained a lot from the course.
Boehringer Ingelheim
Oramon Nimkannon, Capability Lead Pricing & Contracting - Germany - April 2025
A great introduction to exploring the complexity of achieving value for patients in the US.
UCB
Sophie Housiaux, Equitable Access & Policy Lead - Belgium - April 2025
Great presentations on the key players in US Market Access, clearly explaining unique payer drivers and the pricing and access decision-making processes in the US. I also enjoyed the insightful discussions around future outlooks and the potential impact of new legislation.
Boehringer Ingelheim
Sine Ilday, Senior Manager Global HCA & Market Access - Germany - April 2025
I can highly recommend this course! Nick and Louisa gave a very clear presentation of the US Market Access systems.
GSK
Florian Toussaint, Market Access and Public Affairs Manager - France - September 2024
Special thanks to Louisa and Nick for their ability to explain complex subjects in a comprehensive manner. I also really appreciate the quality of the provided materials.
Medincell
Bérengère Duhamel, Business Insight and Market Access Leader - France - September 2024
I highly appreciate the structured and business-focused approach in explaining complex healthcare issues with a clear and simple-to-understand story.
Olpha
Elena Bushberg, Executive Director - Latvia - September 2024
People attending this course are typically also interested in the below courses.
Need help to find the right course? Email Inge Cornelis (Director, Client & Product Projects) or call +32 473 65 15 77